Tillotts Pharma AG
Records under this name other than the patents Tillotts Pharma AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,529,326 | Eflornithine and Sulindac, Fixed Dose Combination Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 11,925,613 | Eflornithine and Sulindac, Fixed Dose Combination Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 12,350,246 | Eflornithine and Sulindac, Fixed Dose Combination Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 10,973,790 | Eflornithine and Sulindac, Fixed Dose Combination Formulation Formerly held In force · High confidence | In force | High confidence | |
| US 11,717,484 | Topical Treatment of Inflammatory Bowel Disease Using Antibodies and Fragments Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,895,314 | Delayed release pharmaceutical formulation containing porous carrier particles for colon targeting Lapsed on the fee record Ended Feb 20, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 20, 2026 | From the USPTO record |
| US 8,383,678 | Type a gelatin capsule containing PUFA in free acid form Lapsed on the fee record Ended Feb 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Feb 26, 2025 | From the USPTO record |
| US 9,364,440 | A Delayed Release Drug Formulation Lapsed on the fee record Ended Jun 14, 2024 · Medium confidence | Lapsed on the fee record | Ended Jun 14, 2024 | Medium confidence |
| US 10,391,061 | Delayed release pharmaceutical formulation and methods of making and using same Lapsed on the fee record Ended Aug 27, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 27, 2023 | From the USPTO record |
| US 7,960,370 | Type A gelatin capsule containing PUFA in free acid form Lapsed on the fee record Ended Jun 14, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2023 | From the USPTO record |